Blog Archive

Showing posts with label BUYBACK REVERSE. Show all posts
Showing posts with label BUYBACK REVERSE. Show all posts

Tuesday, January 17, 2023

CRDL reverse buy back

NET LOSS 71.90 %  
AVG 2.72 (CURRENT VALUE 0.765) 
ST
ID stock number price Field1 plan current price share amount current lost price net loss fill amount filled price fill total grand total grand share grand avg GAP
5 CRDL $92.00 $2.72 $250.24
$0.67 $92.00 $61.64 ($188.60) $0.00 $0.00 $0.00 $250.24 $92.00 $2.72
  REPURCHASE 
ST
ID stock number price Field1 plan current price share amount current lost price net loss fill amount filled price fill total grand total grand share grand avg GAP
6 CRDL $101.00 $0.77 $77.27
$0.78 $101.00 $78.29 $1.02 $0.00 $0.00 $0.00 $77.27 $101.00 $0.77
 
ST
ID stock number price Field1 plan current price share amount current lost price net loss fill amount filled price fill total grand total grand share grand avg GAP
6 CRDL $101.00 $0.77 $77.27
$0.77 $100.00 $76.50 ($0.77) $0.00 $0.00 $0.00 $77.27 $101.00 $0.77

Cardiol Therapeutics Inc. (NASDAQ: CRDL) is a clinical-stage life sciences company specializing in anti-inflammatory and anti-fibrotic therapies for heart diseases.

Cardiol Therapeutics Inc (CRDL)
$1.37
+$0.08(+6.64%)Today
$1.47+$0.10(+7.30%)Pre-Market

Financial Overview:

  • Revenue: For the fiscal year ending December 31, 2023, Cardiol Therapeutics reported minimal revenue, consistent with its status as a clinical-stage company.

  • Net Loss: The company recorded a net loss of approximately $20.84 million for the same period, reflecting ongoing research and development expenditures.

  • Cash Position: As of December 31, 2023, the company held cash and short-term investments totaling approximately $34.93 million, providing a financial runway for its clinical programs.

Analyst Ratings and Price Targets:

  • Consensus Rating: Cardiol Therapeutics has received a consensus rating of "Buy" from multiple analysts, indicating optimism about the company's prospects.

  • Price Targets: The average twelve-month price target is $8.75, with estimates ranging from $7.89 to $10.00, suggesting a significant potential upside from the current share price.

  • Recent Analyst Activity: On December 18, 2024, HC Wainwright reiterated a "Buy" rating with a $9.00 price target, reflecting confidence in the company's strategic direction.

Recent Developments:

  • Clinical Trials: 

  • The company has completed patient enrollment in its Phase II 

  • MAvERIC-Pilot study investigating CardiolRx™ for recurrent pericarditis, with topline results expected in Q2 2024.

  • Regulatory Designations: CardiolRx™ has been granted Orphan Drug Designation by the U.S. FDA for the treatment of pericarditis, potentially expediting its development and approval process.

Considerations for Investors:

While Cardiol Therapeutics shows promise with its innovative therapies and favorable analyst outlook, potential investors should be mindful of the inherent risks associated with clinical-stage biotech companies, including regulatory hurdles, clinical trial outcomes, and market competition.

It's advisable to conduct thorough due diligence and consider these factors when evaluating investment opportunities in the biotech sector.


 

CALA REVERSE BUY BACK

TODAY SELL OFF CALA AND BUY BACK

NET LOSS 22 $ TO GET BACK CALA 

RIGHT NOW GAIN 1.29 

TO WAIT TILL 22 $ TRADE IN AND OUT







MULN reverse net loss 40$ buy 600 share

 NET LOSS 303 $ GAIN 80 $ TO GET 223

  NET LOSS 40 $ GAIN 0   $ TO GET 40 

TO GET TOTAL 263 $

MULN SELL OFF  4  JAN    2023 1100 SHARE 0.32  TOTAL 352 $ 
MULN SELL OFF     29 DEC  2022 1000 SHARE 0.26 TOTAL 260 $

 
 
ID stock number price TOTAL PRICE plan current price NUMBER OF SHARE current lost price net loss fill amount filled price fill total grand total grand share grand avg GAP
15 MULN $520.00 $0.22 $115.28
$0.22 $520.00 $112.22 ($3.07) $520.00 $0.22 $112.27 $227.55 $1,040.00 $0.22
14 MULN $520.00 $0.80 $416.00
$0.22 $520.00 $112.22 ($303.78) $0.00 $0.00 $0.00 $416.00 $520.00 $0.80
23 MULN $4,000.00 $0.24 $960.00
$0.30 $4,000.00 $1,200.00 $240.00 $0.00 $0.00 $0.00 $960.00 $4,000.00 $0.24
 

Friday, December 30, 2022

UAVS as of 12/30 /2022

 

 My stock market value

Your market value

$32.00

Today‘s return
+$0.42 (+1.33%)
Total return
-$219.41 (-87.27%)
Your average cost2.51

Shares        100

Portfolio diversity
0.86%








AgEagle Aerial Systems, Inc. engages in the design and manufacture of drones for commercial use. The firm also enables the capturing, imaging, editing, and analyzing of images and data captured by drones and intends on using commercial drones to be used for delivery services of goods. It offers contract manufacturing, drone solutions, and agriculture solutions. The company was founded on March 31, 1999 and is headquartered in Wichita, KS (. The listed name for UAVS is AgEagle Aerial Systems, Inc.

City Hall Wichita, Kansas 



  AgEagle Aerial Systems stock split history picture
AgEagle Aerial Systems (UAVS) has 1 split in our AgEagle Aerial Systems stock split history database. The split for UAVS took place on March 27, 2018. This was a 1 for 25 reverse split, meaning for each 25 shares of UAVS owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 40 share position following the split.

When a company such as AgEagle Aerial Systems conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. 

Looking at the AgEagle Aerial Systems stock split history from start to finish, an original position size of 1000 shares would have turned into 40 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into AgEagle Aerial Systems shares, starting with a $10,000 purchase of UAVS, presented on a split-history-adjusted basis factoring in the complete AgEagle Aerial Systems stock split history. 

  • Start date:     01/02/2013     

  • End date:     12/29/2022     

  • Start price/share:     $12.50     

  • End price/share:     $0.32     

  • Dividends collected/share:     $0.00     

  • Total return:     -97.44%     

  • Average Annual Total Return:     -30.70%     

  • Starting investment:     $10,000.00     

  • Ending investment:     $255.98     

  • Years:     9.99    

 

IDEX reverse split compare 1 week 1 month 3 month 1 year to invest long term to check financial


 
 
 
 
 
 
 
 
 
 
 
 
Market cap as  of 4/4/2024
11.81M
Price-Earnings ratio
-0.02
Dividend yield
Average volume
507.12K
High today
$1.05
Low today
$0.9753
Open price
$1.00
Volume
296.89K
52 Week high
$16.13
52 Week low
$0.88

The average Ideanomics stock price prediction forecasts a potential upside of 1,204.35% from the current IDEX share price of $0.23. 
 

  • Ideanomics (IDEX): Forward revenue estimates point to a robust future ahead for the business

 
 The 1 analysts offering 12-month price forecasts for Ideanomics Inc have a median target of 1.00, with a high estimate of 1.00 and a low estimate of 1.00. The median estimate represents a +586.34% increase from the last price of 0.15. 
 
Ideanomics (NASDAQ: IDEX), a global company focused on accelerating the commercial adoption of electric vehicles (EV), today announces that its subsidiary Energica now has 24 certified dealers in the United States, which accounts for 33% of product sales.

02/06/2023 Ideanomics Inc (IDEX) stock has fallen -82.35% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives IDEX stock a score of 34 out of a possible 100.


What this means: InvestorsObserver gives Ideanomics Inc (IDEX) an overall rank of 34, which is below average. Ideanomics Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 34 means that 66% of stocks appear more favorable to our system.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.


  • Ideanomics (IDEX): Forward revenue estimates point to a robust future ahead for the business

Ideanomics Inc (IDEX) Analyst Forecast

Next 12 months ➝Current Price$0.1752-week High$1.1552-week Low$0.14FORECAST$1.00+480.72%i
Index 97.83% down 45.26 dollar net loss as of 5/9/2025

IDEX Price, Volume, Earnings, and Dividend Date

  • Last Price$0.17
  • Previous Close$0.17
  • Change$0.00
  • Open$0.19
  • Volume22,413,560
  • Avg. Volume (100-day)9,949,718
  • Market Cap101,503,787
  • Days Range0.1722 - 0.1853
  • 52-week Range0.14 - 1.15
  • Dividend Yield
  • Ex. Dividend Date
  • P-E
  • EPS
  • Earnings Date02/07/23
  • SectorTechnology
  • IndustrySoftware - Application
  • Avg. Analyst Rec.Premium
  • Beta1.904
  • PEG Ratio

Monday, November 21, 2022

ANY FILL THE SHORT

 95 % DOWN  

108 SHARE 

AVG 6.74 

PERCENTAGE ( - 94.88 %  ) 

Net loss -692.55 (95%) 

1: 1000 SHARE 

100 x 10000 0.36 gap ( 5 to 6 cent  ) 

current 0.3268 to 0.34 cent

STOCK -FILL THE SHORT TABLE
ID STOCK REMARK PRICE BROKER DATE AND TIME PRICES AMOUNT Field1 number fill prices fill dollar total filled total unit average NET LOSS Field2 REMARK
306 ANY


$6.74 108 $727.92 10800 $0.33 $3,529.44 $4,257.36 10908 $0.39 0

STOCK -FILL THE SHORT TABLE
ID STOCK REMARK PRICE BROKER DATE AND TIME PRICES AMOUNT Field1 number fill prices fill dollar total filled total unit average NET LOSS Field2 REMARK
306 ANY


$0.74 108 $79.92 1080 $0.33 $352.94 $432.86 1188 $0.36 0